SI
AMRI

SII Investments’s Albany Molecular Research Inc AMRI Stock Holding History

SII Investments’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,460
Closed -$161K – 647
2017
Q1 		$161K Buy
11,460
+250
+2% +$4.09K 0.01% 576
2016
Q4 		$211K Hold
11,210
– – 0.02% 537
2016
Q3 		$186K Buy
+11,210
New +$166K 0.01% 556
2016
Q2 		– Sell
-10,695
Closed -$163K – 630
2016
Q1 		$163K Buy
+10,695
New +$168K 0.02% 529
2015
Q4 		– Sell
-10,695
Closed -$186K – 565
2015
Q3 		$186K Buy
+10,695
New +$218K 0.02% 498

Other funds holding AMRI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

SII Investments's AMRI Position: Q2 2017 in Review

SII Investments sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 11,460 shares — an estimated $161K sold.

SII Investments first reported a position in AMRI in Q3 2015 and held it in 5 quarters. The position peaked at $211K in Q4 2016. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

  • SII Investments reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
  • SII Investments sold 11,460 Albany Molecular Research Inc shares in Q2 2017, an estimated $161K.
  • SII Investments first reported a position in Albany Molecular Research Inc in Q3 2015 and held it in 5 quarters.
  • SII Investments's Albany Molecular Research Inc position peaked at $211K in Q4 2016.
  • 136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on SII Investments's 13F filing for Q2 2017, filed 14 Aug 2017.